Aflibercept in branch retinal vein occlusion as second line therapy: clinical outcome 12 months after changing treatment from bevacizumab/ranibizumab—a pilot study
Crossref DOI link: https://doi.org/10.1186/s40942-016-0045-8
Published Online: 2016-08-23
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wirth, Magdalena A.
Becker, Matthias D.
Graf, Nicole
Michels, Stephan
Funding for this research was provided by:
Werner H. Spross Foundation
